연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1482 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Alotaibi, Ahmad S. | Alotaibi, AS | 10 | King Faisal Specialist Hosp & Res Ctr, Canc Ctr Excellence, Dept Hematol Stem Cell Transplantat & Cellular The, Riyadh, Saudi Arabia | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Saad, Ayman | Saad, A | 11 | King Faisal Specialist Hosp & Res Ctr KFSHRC, Riyadh, Saudi Arabia | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Alhuraiji, Ahmad | Alhuraiji, A | 12 | Kuwait Canc Ctr, Shuwaikh, Kuwait | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Al-Khabori, Murtadha | Al-Khabori, M | 13 | Sultan Qaboos Univ, Muscat, Oman | I-4774-2019 | Khabori, Murtadha | ||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Bazarbachi, Ali | Bazarbachi, A | 14 | Amer Univ Beirut, Dept Med, Beirut, Lebanon | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Zeiser, Robert | Zeiser, R | 15 | Albert Ludwigs Univ ALU, Univ Freiburg, Fac Med, Freiburg, Germany | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Mehra, Varun | Mehra, V | 16 | Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England | AAS-1390-2020 | Mehra, Varun | ||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Ahn, Jae-Sook | Ahn, JS | 17 | Chonnam Natl Univ, Hwasun Hosp, Gwangju, Jeollanam Do, South Korea | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Kim, Hyeoung-Joon | Kim, HJ | 18 | Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Moon, Joon Ho | Moon, JH | 19 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Sohn, Sang Kyun | Sohn, SK | 20 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Cai, Yu | Cai, Y | 21 | Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Song, Xianmin | Song, XM | 22 | Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Huang, Xiao Jun | Huang, XJ | 23 | Peking Univ, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplantat, Natl Clin Res Ctr Hematol Dis,Inst Hematol, Beijing, Peoples R China | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Ye, Yishan | Ye, YS | 24 | Zhejiang Univ, Afliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China | G-3886-2018 | Ye, Yishan |
페이지 이동: